Brainstorm Cell Therapeutics | BCLI - PE Price to Earnings

Stock Price
0.85
Daily Change
-0.02 -1.73%
Monthly
-5.56%
Yearly
6.92%
Q2 Forecast
0.90

Brainstorm Cell Therapeutics reported 0.03 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Biogen 14.02 4.63 Dec/2025
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Cipla 27.74 3.55 Dec/2025
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
CSL 16.16 9.59 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
Grifols 11.2 1.08 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025